Response to inhaled granulocyte‐macrophage colony‐stimulating factor in patient with mild‐to‐moderate autoimmune pulmonary alveolar proteinosis—24 months of follow‐up

Response to inhaled granulocyte‐macrophage colony‐stimulating factor in patient with mild‐to‐moderate autoimmune pulmonary alveolar proteinosis—24 months of follow‐up

Abstract Introduction Autoimmune pulmonary alveolar proteinosis (aPAP) is a disease caused by IgG antibodies against granulocyte‐macrophage colony‐stimulating factor (GM‐CSF). Whole lung lavage (WLL) allows to remove the lipo‐proteinaceous material accumulated by the poor clearance of alveolar surfa...

Full description

Bibliographic Details
Main Authors: Iván Oterino‐Moreira, María‐Jesús Linares‐Asensio, Sira Sanz‐Márquez, Montserrat Pérez‐Encinas
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:The Clinical Respiratory Journal
Subjects:
aerosol drug therapy
granulocyte‐macrophage colony‐stimulating factor
inhalation drug administration
pulmonary alveolar proteinosis
sargramostim
Online Access:https://doi.org/10.1111/crj.13650

Internet

https://doi.org/10.1111/crj.13650

Similar Items